SCHEMBL20038071

SCHEMBL20038071

CCOCC1CCN(c2ccc(C)nc2)CC1

nearest known ligand 0.41

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ PRKDC P78527 1/20 0.41
▸ CHRNB1 P11230 1/20 0.41
▸ CHRNB2 P17787 1/20 0.41
▸ CHRNB4 P30926 1/20 0.41
▸ CHRNA3 P32297 1/20 0.41
▸ CHRNA4 P43681 1/20 0.41
▸ CHRNB3 Q05901 1/20 0.41
▸ USP1 O94782 1/20 0.40
▸ WDR48 Q8TAF3 1/20 0.40
▸ HRH3 Q9Y5N1 7/20 0.40
▸ HRH4 Q9H3N8 1/20 0.40
▸ ELANE P08246 1/20 0.39
▸ SMO Q99835 1/20 0.38
▸ PIK3CA P42336 3/20 0.37
▸ MTOR P42345 3/20 0.37
▸ CHRM2 P08172 1/20 0.36
▸ CHRM1 P11229 1/20 0.36
▸ CHRM3 P20309 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15859901 0.83 CDK1 (0.45) CHRNB1CHRNB2CHRNB4CHRNA3CHRNA4
SCHEMBL24632524 0.78 AKT2 (0.44) CHRNB2CHRNA4USP1WDR48HRH3
SCHEMBL31625156 0.78 AKT2 (0.44) CHRNB2CHRNA4USP1WDR48HRH3
SCHEMBL28263429 0.78 HRH3 (0.48) HRH3
SCHEMBL12595589 0.78 PIK3CA (0.51) CHRNB2CHRNA4USP1WDR48HRH3
SCHEMBL17297771 0.77 USP1 (0.47) CHRNB1CHRNB2CHRNB4CHRNA3CHRNA4
SCHEMBL21180884 0.76 MAPT (0.62) —
SCHEMBL17664587 0.76 MAPT (0.49) CHRNB1CHRNB2CHRNB4CHRNA3CHRNA4
SCHEMBL17297906 0.76 USP2 (0.49) CHRNB1CHRNB2CHRNB4CHRNA3CHRNA4
SCHEMBL24681513 0.76 USP1 (0.42) CHRNB1CHRNB2CHRNB4CHRNA3CHRNA4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3305785-A1 PYRIDO[3,4-d]PYRIMIDINE DERIVATIVE AND PHARMACEUTICALLY ACCEPTABLE SALT THEREOF Teijin Pharma Limited (JP) 2018-04-11 — — EP disclosed
Send feedback